Tag Archives: PrEPfocused

Unsuccessful in licensing talks, feds sue Gilead over PrEP-focused HIV patent

Gilead Sciences balked at licensing the U.S. government’s HIV-prevention patent rights, and now the feds are striking back. The Department of Health and Human Services sued Gilead for patent infringement Wednesday, saying the company and its HIV prophylaxis meds Truvada and Descovy reaped profits off hundreds of millions of dollars in taxpayer-funded research. The patent dust-up… Read More »